𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation

✍ Scribed by C. Margarit; A. Rimola; I. Gonzalez-Pinto; V. Cuervas-Mons; A. Edo; H. Andreu; E. Moreno-Gonzalez; J. L. Calleja

Publisher
Springer
Year
1998
Tongue
English
Weight
250 KB
Volume
11
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics, efficacy, and safety o
Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients
✍ BjΓΆrn Nashan; Faouzi Saliba; Francois Durand; Rafael BarcΓ©na; Jose Ignacio Herre πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 455 KB πŸ‘ 1 views

The pharmacokinetics of mycophenolate mofetil (MMF) in liver transplant recipients may change because of pharmacokinetic interactions with coadministered immunosuppressants or because changes in the enterohepatic anatomy may affect biotransformation of MMF to mycophenolic acid (MPA) and enterohepati

Efficacy and safety of low-dose valganci
Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients
✍ Jeong M. Park; Kathleen D. Lake; Juan D. Arenas; Robert J. Fontana πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

The efficacy and safety of valganciclovir (VGCV) for cytomegalovirus (CMV) prophylaxis in liver transplant recipients has not been established. We retrospectively compared the efficacy and safety of low-dose oral VGCV (450 mg once daily for 90 days) and standard oral ganciclovir (1 g three times a d

Efficacy and safety of repeated perioper
Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation
✍ J. Peter A. Lodge; Sven Jonas; Robert M. Jones; Michael Olausson; JosΓ© Mir-Palla πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

## Patients undergoing orthotopic liver transplantation (OLT) have excessive blood loss during surgery that requires blood transfusions, leading to increased postoperative morbidity and mortality. We studied the efficacy and safety of activated recombinant factor VII (rFVIIa) in reducing transfusio